• 1
    Lippes J, Malik T, Tatum HJ. The postcoital copper-T. Adv Plan Parent 1976;11:249.
  • 2
    Cheng L, Gulmezoglu AM, Piaggio G, Ezcurra E, Van Look PF. Interventions for emergency contraception. Cochrane Database Syst Rev 2008:CD001324.
  • 3
    von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bartfai G, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002;360:180310.
  • 4
    Zhou L, Xiao B. Emergency contraception with Multiload Cu-375 SL IUD: a multicenter clinical trial. Contraception 2001;64:10712.
  • 5
    Sivin I. Utility and drawbacks of continuous use of a copper T IUD for 20 years. Contraception 2007;75:S705.
  • 6
    Forrest JD. U.S. women’s perceptions of and attitudes about the IUD. Obstet Gynecol Surv 1996;51:S304.
  • 7
    Hubacher D, Grimes DA. Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv 2002;57:1208.
  • 8
    Hov G, Skjeldestad F, Hilstad T. Use of IUD and subsequent fertility—follow-up after participation in a randomized clinical trial. Contraception 2007;75:8892.
  • 9
    Hubacher D, Lara-Ricalde R, Taylor DJ, Guerra-Infante F, GuzmanRodriguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001;345:5617.
  • 10
    Scientific Group of the World Health Organization. Medical Eligibility Criteria for Contraceptive Use. Geneva: World Health Organization, 2004.
  • 11
    Penney G, Brechin S, de Souza A, Bankowska U, Belfield T, Gormley M, et al. FFPRHC Guidance (January 2004). The copper intrauterine device as long-term contraception. J Fam Plann Reprod Health Care 2004;30:2941; quiz 2.
  • 12
    Intrauterine device. ACOG Practice Bulletin No. 59. American College of Obstetricians and Gynecologists. Obstet Gynecol 2005;105:22332.
  • 13
    Allen RH, Goldberg AB, Grimes DA. Expanding access to intrauterine contraception. Am J Obstet Gynecol 2009;201:456e15.
  • 14
    World Health Organization. Long-term reversible contraception. Twelve years experience with the TCu380A and TCu220c. Contraception 1997;56:34152.
  • 15
    Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000;356:10139.
  • 16
    Caliskan E, Ozturk N, Dilbaz BO, Dilbaz S. Analysis of risk factors associated with uterine perforation by intrauterine devices. Eur J Contracept Reprod Health Care 2003;8:1505.
  • 17
    Bastianelli C, Farris M, Benagiano G. Emergency contraception: a review. Eur J Contracept Reprod Health Care 2008;13:916.
  • 18
    Trussell J, Ellertson C, von Hertzen H, Bigrigg A, Webb A, Evans M, et al. Estimating the effectiveness of emergency contraceptive pills. Contraception 2003;67:25965.
  • 19
    Collett D. Modelling Survival Data in Medical Research, 2nd edn. Boca Raton, FL: Chapman & Hall/CRC, 2003.
  • 20
    Luerti M, Tonta A, Ferla P, Molla R, Santini F. Post-coital contraception by estrogen/progestagen combination or IUD insertion. Contraception 1986;33:618.
  • 21
    Raymond EG, Trussell J, Polis CB. Population effect of increased access to emergency contraceptive pills: a systematic review. Obstet Gynecol 2007;109:1818.
  • 22
    Polis CB, Schaffer K, Blanchard K, Glasier A, Harper CC, Grimes DA. Advance provision of emergency contraception for pregnancy prevention (full review). Cochrane Database Syst Rev 2007:CD005497.
  • 23
    Meirik O, Rowe PJ, Peregoudov A, Piaggio G, Petzold M. The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an 8-year multicenter randomized comparative trial. Contraception 2009;80:13341.
  • 24
    Rivera R, Chen-Mok M, McMullen S. Analysis of client characteristics that may affect early discontinuation of the TCu-380A IUD. Contraception 1999;60:15560.
  • 25
    Kulier R, O’Brien PA, Helmerhorst FM, Usher-Patel M, D’Arcangues C. Copper containing, framed intra-uterine devices for contraception. Cochrane Database Syst Rev 2007:CD005347.